Logo

NCI Approves New $104M Clinical Proteomics Technologies Initiative

Jul 01, 2005

NEW YORK, July 1 (GenomeWeb News) - The National Cancer Institute's Board of Scientific Advisors has approved a five-year, $104 million budget for a new program aimed at optimizing current proteomic technologies.

 

The program, called the Clinical Proteomics Technologies Initiative, hopes to optimize current proteomic technologies by improving reproducibility, standardization of data formats, throughput capabilities, sample preparation and handling, sensitivity, and specificity.

 

In addition, the program aims to develop new technologies, reagents, systems, and working consortia to advance the field of cancer proteomics research. Funding for the program will be given out over five years.

 

According to Gregory Downing, the director of NCI's Office of Technology and Industrial Relations, the NCI will issue requests for applications and request for proposals for the new program in the fall.

Breaking News
The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.